Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID DTD0019 Transporter Info
Gene Name SLC10A1
Transporter Name Sodium/taurocholate cotransporting polypeptide
Gene ID
6554
UniProt ID
Q14973

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        CEBPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC10A1 gene in hepatocellular carcinoma condition [1]

TF Protein Name

 CCAAT/enhancer-binding protein alpha Transcription Factor Info

Studied Phenotype

 Hepatocellular carcinoma [ICD11: 2C12.02]

Tissue

 Liver

Related DT Changes

 Up regulating

Experimental Material

 Rat hepatocellular carcinoma cells (Fao)

Detailed Description

 CCAAT/enhancer-binding protein alpha (CEBPA) has been reported to activate the transcription of SLC10A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

        CEBPB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC10A1 gene in hepatocellular carcinoma condition [1]

TF Protein Name

 CCAAT/enhancer-binding protein beta Transcription Factor Info

Studied Phenotype

 Hepatocellular carcinoma [ICD11: 2C12.02]

Tissue

 Liver

Related DT Changes

 Up regulating

Experimental Material

 Rat hepatocellular carcinoma cells (Fao)

Detailed Description

 CCAAT/enhancer-binding protein beta (CEBPB) has been reported to activate the transcription of SLC10A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        NR1H4 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC10A1 gene in hepatoblastoma condition [2]

TF Protein Name

 Bile acid receptor Transcription Factor Info

Studied Phenotype

 Hepatoblastoma [ICD11: 2C12.01]

Tissue

 Liver

Related DT Changes

 Down regulating

Experimental Material

 Human hepatoblastoma cells (HepG2)

Detailed Description

 Bile acid receptor (NR1H4) has been reported to repress the transcription of SLC10A1 gene in hepatoblastoma condition, which leads to a decreased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

       Transcriptional Phenomenon 2

 Repression of SLC10A1 gene in bile duct ligation condition [3]

TF Protein Name

 Bile acid receptor Transcription Factor Info

Studied Phenotype

 Bile duct ligation [N.A]

Tissue

 Liver

Related DT Changes

 down regulating

Experimental Material

 C57/BL6 mice

Detailed Description

 Bile acid receptor (NR1H4), influenced by the exogenous cholic acid, has been reported to repress the transcription of SLC10A1 gene in bile duct ligation condition , which leads to a decreased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

        NR1I2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC10A1 gene in health condition [4]

TF Protein Name

 Nuclear receptor subfamily 1 group I member 2 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Related DT Changes

 Up regulating

Detailed Description

 Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the metabolite from Host unspecified microbiota, has been reported to activate the transcription of SLC10A1 gene in health condition, which leads to an increased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

        NR1I3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC10A1 gene in health condition [5]

TF Protein Name

 Nuclear receptor subfamily 1 group I member 3 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Liver

Related DT Changes

 down regulating

Experimental Material

 Human primary human hepatocytes

Detailed Description

 Nuclear receptor subfamily 1 group I member 3 (NR1I3), influenced by the exogenous phenobarbital, has been reported to repress the transcription of SLC10A1 gene in health condition , which leads to a decreased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

        RARA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC10A1 gene in hepatocellular carcinoma condition [6]

TF Protein Name

 Retinoic acid receptor alpha Transcription Factor Info

Studied Phenotype

 Hepatocellular carcinoma [ICD11: 2C12.02]

Tissue

 Liver

Related DT Changes

 up regulating

Experimental Material

 Human hepatocellular carcinoma (HepaRG)

Detailed Description

 Retinoic acid receptor alpha (RARA), influenced by the exogenous ro-41-5253, has been reported to activate the transcription of SLC10A1 gene in hepatocellular carcinoma condition , which leads to an increased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        HNF1A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC10A1 gene in sepsis condition [7]

TF Protein Name

 Hepatocyte nuclear factor 1-alpha Transcription Factor Info

Studied Phenotype

 Sepsis [ICD11: 1G40-1G41]

Tissue

 Liver

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6 mice

Detailed Description

 Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of SLC10A1 gene in sepsis condition, which leads to an increased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

        ONECUT1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC10A1 gene in health condition [8]

TF Protein Name

 Hepatocyte nuclear factor 6 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Liver

Related DT Changes

 Up regulating

Experimental Material

 Mouse liver hepatic sinusoidal endothelial cells (SV40LG)

Detailed Description

 Hepatocyte nuclear factor 6 (ONECUT1) has been reported to activate the transcription of SLC10A1 gene in health condition, which leads to an increased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

      Class 3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        FOXA2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC10A1 gene in hepatocellular carcinoma condition [9]

TF Protein Name

 Hepatocyte nuclear factor 3-beta Transcription Factor Info

Studied Phenotype

 Hepatocellular carcinoma [ICD11: 2C12.02]

Tissue

 Liver

Related DT Changes

 Down regulating

Experimental Material

 Human adult hepatocellular carcinoma cells (Huh7)

Detailed Description

 Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to repress the transcription of SLC10A1 gene in hepatocellular carcinoma condition, which leads to a decreased expression of the drug transporter Sodium/taurocholate cotransporting polypeptide.

      Class 3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        FLI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC10A1 gene [10]

TF Protein Name

 Friend leukemia integration 1 transcription factor Transcription Factor Info

Tissue

 Blood; Mesenchymal

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC10A1 gene, which in turn affects the expression or function of the drug transporter Sodium/taurocholate cotransporting polypeptide.
References
1 Structural and functional characterization of liver cell-specific activity of the human sodium/taurocholate cotransporter. Genomics. 2000 Oct 15;69(2):203-13.
2 Hepatobiliary transport of bile acids and organic anions. J Hepatobiliary Pancreat Surg. 2002;9(4):443-7.
3 Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiol Gastrointest Liver Physiol. 2005 Nov;289(5):G798-805.; 2005 Nov;289(5):G798-805.
4 Intestinal flora induces the expression of Cyp3a in the mouse liver. Xenobiotica. 2009 Apr;39(4):323-34.
5 Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos. 2006 Oct;34(10):1756-63.
6 Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression. J Biol Chem. 2015 Feb 27;290(9):5673-84.
7 IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock. 2008 Apr;29(4):490-6.
8 Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts. Am J Physiol Gastrointest Liver Physiol. 2010 Sep;299(3):G769-77.
9 Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G752-61.
10 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-183. (ID:ENSG00000100652)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.